Psychiatry & Neurology Doctors in Glenwood Springs, CO Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Peter Wiley, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1906 Blake Ave, Glenwood Springs, CO 81601 Phone: 970-384-6710    Fax: 970-384-7536

Dr. George M Anderson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 6916 Highway 82, Glenwood Springs, CO 81601 Phone: 970-945-2583

Craig Patton Bushong, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 6916 Highway 82, Glenwood Springs, CO 81601 Phone: 970-945-2583    Fax: 970-928-8852

David Conklin, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 2802 Grand Ave, Glenwood Springs, CO 81601 Phone: 970-945-2583

News Archive

University Hospital Bonn to validate accuracy of VolitionRx's Nucleosomics technology in lung cancer

VolitionRx Limited, a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced that the University Hospital Bonn in Germany will initiate a clinical confirmatory study to assess VolitionRx's proprietary Nucleosomics platform technology for the diagnosis of lung cancer through a blood test in individuals.

Provectus announces final data from PV-10 Phase 2 trial on metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that Phase 2 final data on PV-10 for metastatic melanoma will be presented at the 2nd European PostASCO Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.

SaneVax Team congratulates Senator for examining NCI ethical questions

In a letter addressed to U.S. Senator Charles Grassley, the SaneVax Team congratulated the senator on his recent efforts to examine ethical questions raised by National Cancer Institute (NCI) employees accepting extensive travel sponsored by private companies and identified two senior NCI scientists who knowingly promote unreliable human papillomavirus (HPV) tests for patient care, and the development/monitoring of genotype-specific HPV vaccines to promote an unproven virology-based cervical cancer prevention business agenda.

Prasco Laboratories to market Stiefel Laboratories' Clobetasol Propionate Foam

Prasco Laboratories announced today that they have signed a distribution and supply agreement with Stiefel Laboratories, Inc., a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest product in Prasco's line of authorized generics. Under the terms of the agreement, Prasco will market and distribute Clobetasol Propionate Foam 0.05% in 50g and 100g canisters in the U.S. under the Prasco label.

Read more Medical News

› Verified 7 days ago